Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $4.2300 (0.95%) ($4.2300 - $4.2300) on Fri. Apr. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.54% (three month average) | RSI | 66 | Latest Price | $4.2300(0.95%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | AUTL advances 0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(72%) IBB(66%) XHB(60%) IBUY(56%) IWO(54%) | Factors Impacting AUTL price | AUTL will decline at least -1.77% in a week (0% probabilities). TIP(-50%) TLT(-26%) SHY(-22%) UNG(-19%) SLV(-11%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.77% (StdDev 3.54%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.21(0.48%) | 10 Day Moving Average | $4.26(-0.7%) | 20 Day Moving Average | $4.12(2.67%) | To recent high | -22.5% | To recent low | 20.7% | Market Cap | $221m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |